McBrinn Sylvia
- SEC CIK
- 0001284666
No open-market purchases or sales filed in the past year.
Current role at each company
- BCAB BioAtla, Inc.Directoras of Jun 18, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists McBrinn Sylvia as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 19, 2024 (view filing) | Mar 28, 2023 | 297 daysLate | McBrinn SylviaDirector | PPurchase | +4.00K | $2.35 | +$9.40K | +26.4%19.1K after | |
| Dec 26, 2023 (view filing) | Dec 26 | Same day | McBrinn SylviaDirector | PPurchase | +4.00K | $2.33 | +$9.32K | +36.0%15.1K after | |
| Sep 13, 2023 (view filing) | Sep 8 | 5 daysLate | McBrinn SylviaDirector | PPurchase | +2.00K | $2.54 | +$5.08K | +21.9%11.1K after | |
| Dec 19, 2022 (view filing) | Dec 19 | Same day | McBrinn SylviaDirector | PPurchase | +3.70K | $8.33 | +$30.8K | +68.2%9.13K after | |
| Nov 23, 2022 (view filing) | Nov 22 | 1 day | McBrinn SylviaDirector | PPurchase | +2.00K | $8.27 | +$16.5K | +58.4%5.42K after | |
| Sep 15, 2022 (view filing) | Sep 12-13 | 3 days | McBrinn SylviaDirector | PPurchase | +3.00K | $8.63 | +$25.9K | New position3.00K after | From original2 lots |